Stephens Consulting, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 111 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
Stephens Consulting, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,310
+1.2%
1,0000.0%0.00%0.0%
Q1 2024$3,270
-6.8%
1,0000.0%0.00%0.0%
Q4 2023$3,510
-47.5%
1,0000.0%0.00%
-66.7%
Q3 2023$6,680
-20.4%
1,0000.0%0.00%0.0%
Q2 2023$8,390
-15.5%
1,0000.0%0.00%
-50.0%
Q1 2023$9,930
+42.7%
1,0000.0%0.01%
+20.0%
Q4 2022$6,960
+30.3%
1,0000.0%0.01%0.0%
Q3 2022$5,340
+33.8%
1,0000.0%0.01%
+66.7%
Q2 2022$3,990
-10.2%
1,0000.0%0.00%
-25.0%
Q1 2022$4,445
-44.4%
1,000
-50.0%
0.00%
-42.9%
Q4 2021$8,0002,0000.01%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 1,877,305$10,025,0005.86%
Prosight Management, LP 1,210,800$6,466,0003.46%
Perceptive Advisors 11,350,085$60,609,0001.76%
JOHNSON & JOHNSON 394,834$2,108,0000.62%
TANG CAPITAL MANAGEMENT LLC 700,000$3,738,0000.46%
APOGEM CAPITAL LLC 85,091$454,0000.45%
683 Capital Management, LLC 700,000$3,738,0000.29%
EAM Investors, LLC 233,638$1,248,0000.27%
Verition Fund Management LLC 4,804,478$12,840,8280.14%
WOODSTOCK CORP 129,179$690,0000.10%
View complete list of ALDEYRA THERAPEUTICS INC shareholders